Trial Profile
Apomorphine nasal powder in the treatment of Parkinson's disease 'off' periods
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Britannia Pharmaceuticals
- 03 Dec 2006 New trial record.